Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global PARP Inhibitor Biomarkers Market, by Product
1.4.2 Global PARP Inhibitor Biomarkers Market, by Application
1.4.3 Global PARP Inhibitor Biomarkers Market, by Services
1.4.4 Global PARP Inhibitor Biomarkers Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Global PARP Inhibitor Biomarkers Market by Product
4.1 Global Kits Market by Region
4.2 Global Assays Market by Region
Chapter 5. Global PARP Inhibitor Biomarkers Market by Application
5.1 Global Breast Cancer Market by Region
5.2 Global Ovarian Cancer Market by Region
5.3 Global Others Market by Region
Chapter 6. Global PARP Inhibitor Biomarkers Market by Services
6.1 Global BRCA 1 & 2 Testing Market by Region
6.2 Global HRD Testing Market by Region
6.3 Global HRR Testing Market by Region
6.4 Global Others Market by Region
Chapter 7. Global PARP Inhibitor Biomarkers Market by Region
7.1 North America PARP Inhibitor Biomarkers Market
7.1.1 North America PARP Inhibitor Biomarkers Market by Product
7.1.1.1 North America Kits Market by Region
7.1.1.2 North America Assays Market by Region
7.1.2 North America PARP Inhibitor Biomarkers Market by Application
7.1.2.1 North America Breast Cancer Market by Country
7.1.2.2 North America Ovarian Cancer Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America PARP Inhibitor Biomarkers Market by Services
7.1.3.1 North America BRCA 1 & 2 Testing Market by Country
7.1.3.2 North America HRD Testing Market by Country
7.1.3.3 North America HRR Testing Market by Country
7.1.3.4 North America Others Market by Country
7.1.4 North America PARP Inhibitor Biomarkers Market by Country
7.1.4.1 US PARP Inhibitor Biomarkers Market
7.1.4.1.1 US PARP Inhibitor Biomarkers Market by Product
7.1.4.1.2 US PARP Inhibitor Biomarkers Market by Application
7.1.4.1.3 US PARP Inhibitor Biomarkers Market by Services
7.1.4.2 Canada PARP Inhibitor Biomarkers Market
7.1.4.2.1 Canada PARP Inhibitor Biomarkers Market by Product
7.1.4.2.2 Canada PARP Inhibitor Biomarkers Market by Application
7.1.4.2.3 Canada PARP Inhibitor Biomarkers Market by Services
7.1.4.3 Mexico PARP Inhibitor Biomarkers Market
7.1.4.3.1 Mexico PARP Inhibitor Biomarkers Market by Product
7.1.4.3.2 Mexico PARP Inhibitor Biomarkers Market by Application
7.1.4.3.3 Mexico PARP Inhibitor Biomarkers Market by Services
7.1.4.4 Rest of North America PARP Inhibitor Biomarkers Market
7.1.4.4.1 Rest of North America PARP Inhibitor Biomarkers Market by Product
7.1.4.4.2 Rest of North America PARP Inhibitor Biomarkers Market by Application
7.1.4.4.3 Rest of North America PARP Inhibitor Biomarkers Market by Services
7.2 Europe PARP Inhibitor Biomarkers Market
7.2.1 Europe PARP Inhibitor Biomarkers Market by Product
7.2.1.1 Europe Kits Market by Country
7.2.1.2 Europe Assays Market by Country
7.2.2 Europe PARP Inhibitor Biomarkers Market by Application
7.2.2.1 Europe Breast Cancer Market by Country
7.2.2.2 Europe Ovarian Cancer Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe PARP Inhibitor Biomarkers Market by Services
7.2.3.1 Europe BRCA 1 & 2 Testing Market by Country
7.2.3.2 Europe HRD Testing Market by Country
7.2.3.3 Europe HRR Testing Market by Country
7.2.3.4 Europe Others Market by Country
7.2.4 Europe PARP Inhibitor Biomarkers Market by Country
7.2.4.1 Germany PARP Inhibitor Biomarkers Market
7.2.4.1.1 Germany PARP Inhibitor Biomarkers Market by Product
7.2.4.1.2 Germany PARP Inhibitor Biomarkers Market by Application
7.2.4.1.3 Germany PARP Inhibitor Biomarkers Market by Services
7.2.4.2 UK PARP Inhibitor Biomarkers Market
7.2.4.2.1 UK PARP Inhibitor Biomarkers Market by Product
7.2.4.2.2 UK PARP Inhibitor Biomarkers Market by Application
7.2.4.2.3 UK PARP Inhibitor Biomarkers Market by Services
7.2.4.3 France PARP Inhibitor Biomarkers Market
7.2.4.3.1 France PARP Inhibitor Biomarkers Market by Product
7.2.4.3.2 France PARP Inhibitor Biomarkers Market by Application
7.2.4.3.3 France PARP Inhibitor Biomarkers Market by Services
7.2.4.4 Russia PARP Inhibitor Biomarkers Market
7.2.4.4.1 Russia PARP Inhibitor Biomarkers Market by Product
7.2.4.4.2 Russia PARP Inhibitor Biomarkers Market by Application
7.2.4.4.3 Russia PARP Inhibitor Biomarkers Market by Services
7.2.4.5 Spain PARP Inhibitor Biomarkers Market
7.2.4.5.1 Spain PARP Inhibitor Biomarkers Market by Product
7.2.4.5.2 Spain PARP Inhibitor Biomarkers Market by Application
7.2.4.5.3 Spain PARP Inhibitor Biomarkers Market by Services
7.2.4.6 Italy PARP Inhibitor Biomarkers Market
7.2.4.6.1 Italy PARP Inhibitor Biomarkers Market by Product
7.2.4.6.2 Italy PARP Inhibitor Biomarkers Market by Application
7.2.4.6.3 Italy PARP Inhibitor Biomarkers Market by Services
7.2.4.7 Rest of Europe PARP Inhibitor Biomarkers Market
7.2.4.7.1 Rest of Europe PARP Inhibitor Biomarkers Market by Product
7.2.4.7.2 Rest of Europe PARP Inhibitor Biomarkers Market by Application
7.2.4.7.3 Rest of Europe PARP Inhibitor Biomarkers Market by Services
7.3 Asia Pacific PARP Inhibitor Biomarkers Market
7.3.1 Asia Pacific PARP Inhibitor Biomarkers Market by Product
7.3.1.1 Asia Pacific Kits Market by Country
7.3.1.2 Asia Pacific Assays Market by Country
7.3.2 Asia Pacific PARP Inhibitor Biomarkers Market by Application
7.3.2.1 Asia Pacific Breast Cancer Market by Country
7.3.2.2 Asia Pacific Ovarian Cancer Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific PARP Inhibitor Biomarkers Market by Services
7.3.3.1 Asia Pacific BRCA 1 & 2 Testing Market by Country
7.3.3.2 Asia Pacific HRD Testing Market by Country
7.3.3.3 Asia Pacific HRR Testing Market by Country
7.3.3.4 Asia Pacific Others Market by Country
7.3.4 Asia Pacific PARP Inhibitor Biomarkers Market by Country
7.3.4.1 China PARP Inhibitor Biomarkers Market
7.3.4.1.1 China PARP Inhibitor Biomarkers Market by Product
7.3.4.1.2 China PARP Inhibitor Biomarkers Market by Application
7.3.4.1.3 China PARP Inhibitor Biomarkers Market by Services
7.3.4.2 Japan PARP Inhibitor Biomarkers Market
7.3.4.2.1 Japan PARP Inhibitor Biomarkers Market by Product
7.3.4.2.2 Japan PARP Inhibitor Biomarkers Market by Application
7.3.4.2.3 Japan PARP Inhibitor Biomarkers Market by Services
7.3.4.3 India PARP Inhibitor Biomarkers Market
7.3.4.3.1 India PARP Inhibitor Biomarkers Market by Product
7.3.4.3.2 India PARP Inhibitor Biomarkers Market by Application
7.3.4.3.3 India PARP Inhibitor Biomarkers Market by Services
7.3.4.4 South Korea PARP Inhibitor Biomarkers Market
7.3.4.4.1 South Korea PARP Inhibitor Biomarkers Market by Product
7.3.4.4.2 South Korea PARP Inhibitor Biomarkers Market by Application
7.3.4.4.3 South Korea PARP Inhibitor Biomarkers Market by Services
7.3.4.5 Singapore PARP Inhibitor Biomarkers Market
7.3.4.5.1 Singapore PARP Inhibitor Biomarkers Market by Product
7.3.4.5.2 Singapore PARP Inhibitor Biomarkers Market by Application
7.3.4.5.3 Singapore PARP Inhibitor Biomarkers Market by Services
7.3.4.6 Malaysia PARP Inhibitor Biomarkers Market
7.3.4.6.1 Malaysia PARP Inhibitor Biomarkers Market by Product
7.3.4.6.2 Malaysia PARP Inhibitor Biomarkers Market by Application
7.3.4.6.3 Malaysia PARP Inhibitor Biomarkers Market by Services
7.3.4.7 Rest of Asia Pacific PARP Inhibitor Biomarkers Market
7.3.4.7.1 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product
7.3.4.7.2 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application
7.3.4.7.3 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services
7.4 LAMEA PARP Inhibitor Biomarkers Market
7.4.1 LAMEA PARP Inhibitor Biomarkers Market by Product
7.4.1.1 LAMEA Kits Market by Country
7.4.1.2 LAMEA Assays Market by Country
7.4.2 LAMEA PARP Inhibitor Biomarkers Market by Application
7.4.2.1 LAMEA Breast Cancer Market by Country
7.4.2.2 LAMEA Ovarian Cancer Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA PARP Inhibitor Biomarkers Market by Services
7.4.3.1 LAMEA BRCA 1 & 2 Testing Market by Country
7.4.3.2 LAMEA HRD Testing Market by Country
7.4.3.3 LAMEA HRR Testing Market by Country
7.4.3.4 LAMEA Others Market by Country
7.4.4 LAMEA PARP Inhibitor Biomarkers Market by Country
7.4.4.1 Brazil PARP Inhibitor Biomarkers Market
7.4.4.1.1 Brazil PARP Inhibitor Biomarkers Market by Product
7.4.4.1.2 Brazil PARP Inhibitor Biomarkers Market by Application
7.4.4.1.3 Brazil PARP Inhibitor Biomarkers Market by Services
7.4.4.2 Argentina PARP Inhibitor Biomarkers Market
7.4.4.2.1 Argentina PARP Inhibitor Biomarkers Market by Product
7.4.4.2.2 Argentina PARP Inhibitor Biomarkers Market by Application
7.4.4.2.3 Argentina PARP Inhibitor Biomarkers Market by Services
7.4.4.3 UAE PARP Inhibitor Biomarkers Market
7.4.4.3.1 UAE PARP Inhibitor Biomarkers Market by Product
7.4.4.3.2 UAE PARP Inhibitor Biomarkers Market by Application
7.4.4.3.3 UAE PARP Inhibitor Biomarkers Market by Services
7.4.4.4 Saudi Arabia PARP Inhibitor Biomarkers Market
7.4.4.4.1 Saudi Arabia PARP Inhibitor Biomarkers Market by Product
7.4.4.4.2 Saudi Arabia PARP Inhibitor Biomarkers Market by Application
7.4.4.4.3 Saudi Arabia PARP Inhibitor Biomarkers Market by Services
7.4.4.5 South Africa PARP Inhibitor Biomarkers Market
7.4.4.5.1 South Africa PARP Inhibitor Biomarkers Market by Product
7.4.4.5.2 South Africa PARP Inhibitor Biomarkers Market by Application
7.4.4.5.3 South Africa PARP Inhibitor Biomarkers Market by Services
7.4.4.6 Nigeria PARP Inhibitor Biomarkers Market
7.4.4.6.1 Nigeria PARP Inhibitor Biomarkers Market by Product
7.4.4.6.2 Nigeria PARP Inhibitor Biomarkers Market by Application
7.4.4.6.3 Nigeria PARP Inhibitor Biomarkers Market by Services
7.4.4.7 Rest of LAMEA PARP Inhibitor Biomarkers Market
7.4.4.7.1 Rest of LAMEA PARP Inhibitor Biomarkers Market by Product
7.4.4.7.2 Rest of LAMEA PARP Inhibitor Biomarkers Market by Application
7.4.4.7.3 Rest of LAMEA PARP Inhibitor Biomarkers Market by Services
Chapter 8. Company Profiles
8.1 Myriad Genetics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segment and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Neogenomics, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Qiagen N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Merck KGaA
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 AstraZeneca PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. GlaxoSmithKline PLC (GSK)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Chapter 9. Winning Imperatives of PARP Inhibitor Biomarkers Market
Unique Offerings 